Research demonstrates that AI can determine the course and severity of aggressive skin cancers, such as Merkel cell carcinoma (MCC), to enhance clinical decision making by generating personalzsed ...

Researchers have identified a promising new speech biomarker that could significantly enrich clinical trials by reducing sample size requirements and enhancing statistical outcomes. By using speech ...

AI models outperform traditional statistics in predicting post-complete cytoreduction outcomes in ovarian cancer patients. AI's diagnostic accuracy was high for predicting overall survival and no ...